# FDA 483 - K.C. Pharmaceuticals, Inc - February 13, 2023

Source: https://www.keypedia.com/records/483/kc-pharmaceuticals-inc/b952ff1f-1c4a-4460-9d04-e1f11c2282e4

> FDA 483 for K.C. Pharmaceuticals, Inc on February 13, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: K.C. Pharmaceuticals, Inc
- Inspection Date: 2023-02-13
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2009-12-30](https://www.keypedia.com/records/483/kc-pharmaceuticals-inc/cf0f74a9-6c8b-4e64-a901-284bbf398402)
- [483 - 2017-11-16](https://www.keypedia.com/records/483/kc-pharmaceuticals-inc/13310105-63c4-44ce-8bd9-876aae4d9f4f)
- [483 - 2020-01-30](https://www.keypedia.com/records/483/kc-pharmaceuticals-inc/62f4d6c3-b675-4e9c-b5a4-08a1a7831a2a)
- [483 - 2020-01-22](https://www.keypedia.com/records/483/kc-pharmaceuticals-inc/950b990d-655f-4672-9906-291af22ed212)
- [483 - 2023-02-13](https://www.keypedia.com/records/483/kc-pharmaceuticals-inc/7f927619-2f9a-494b-bf17-5943a9949adf)

## Related Officers

- [Consumer Safety Officer (Inspector)](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)
- [investigator](https://www.keypedia.com/people/amir-alavi/d7179128-eb3f-489e-97cf-e2c5e5539a00)

Company: https://www.keypedia.com/companies/kc-pharmaceuticals-inc/c82c2f64-5944-429b-a3a9-2f7a567e47d3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c